Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients
IntroductionIn severe COVID-19, direct-acting antiviral drugs were not effective in hyperinflammatory stages and steroid treatment may weaken host immunity. The MEK inhibitor zapnometinib, as a host-targeting drug, has demonstrated promising efficacy a…